APA

Dodd L. E., Korn E. L., Freidlin B., Jaffe C. C., Rubinstein L. V., Dancey J. & Mooney M. M. (20080814). Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Dodd Lori E, Korn Edward L, Freidlin Boris, Jaffe C Carl, Rubinstein Lawrence V, Dancey Janet and Mooney Margaret M. 20080814. Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Dodd L. E., Korn E. L., Freidlin B., Jaffe C. C., Rubinstein L. V., Dancey J. and Mooney M. M. (20080814). Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Dodd Lori E, Korn Edward L, Freidlin Boris, Jaffe C Carl, Rubinstein Lawrence V, Dancey Janet and Mooney Margaret M. Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20080814.